BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22993733)

  • 1. Autoimmune hepatitis: focusing on treatments other than steroids.
    Czaja AJ
    Can J Gastroenterol; 2012 Sep; 26(9):615-20. PubMed ID: 22993733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.
    Czaja AJ
    Inflamm Allergy Drug Targets; 2012 Oct; 11(5):337-50. PubMed ID: 22563779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and prospective pharmacotherapy for autoimmune hepatitis.
    Czaja AJ
    Expert Opin Pharmacother; 2014 Aug; 15(12):1715-36. PubMed ID: 24961409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging treatments for autoimmune hepatitis.
    Czaja AJ
    Curr Drug Targets Inflamm Allergy; 2002 Dec; 1(4):317-26. PubMed ID: 14561179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis.
    Czaja AJ
    Curr Pharm Des; 2011; 17(29):3120-40. PubMed ID: 21902661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug choices in autoimmune hepatitis: part B--Nonsteroids.
    Czaja AJ
    Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):617-35. PubMed ID: 23061712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of autoimmune hepatitis.
    Czaja AJ
    Clin Liver Dis; 2015 Feb; 19(1):57-79. PubMed ID: 25454297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
    Brunt EM; Di Bisceglie AM
    Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions.
    Czaja AJ
    Gut Liver; 2016 Mar; 10(2):177-203. PubMed ID: 26934884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Autoimmune Hepatitis.
    Goel A; Kwo P
    Clin Liver Dis; 2024 Feb; 28(1):51-61. PubMed ID: 37945162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the current treatment of autoimmune hepatitis.
    Czaja AJ
    Dig Dis Sci; 2012 Aug; 57(8):1996-2010. PubMed ID: 22476586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
    Czaja AJ; Carpenter HA
    J Clin Gastroenterol; 2005 Oct; 39(9):819-25. PubMed ID: 16145346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment.
    De Lemos-Bonotto M; Valle-Tovo C; Costabeber AM; Mattos AA; Azeredo-da-Silva ALF
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):212-216. PubMed ID: 29227329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage Therapies for Autoimmune Hepatitis: A Critical Review.
    Roberts SK; Kemp W
    Semin Liver Dis; 2017 Nov; 37(4):343-362. PubMed ID: 29272896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies in autoimmune hepatitis.
    Czaja AJ
    Clin Liver Dis; 2002 Aug; 6(3):799-824. PubMed ID: 12362582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapy for autoimmune hepatitis.
    Montano Loza AJ; Czaja AJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Apr; 4(4):202-14. PubMed ID: 17404588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical treatment for autoimmune hepatitis through corticosteroid to new immunosuppressive agents: a concise review.
    Soloway RD; Hewlett AT
    Ann Hepatol; 2007; 6(4):204-7. PubMed ID: 18007548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of autoimmune hepatitis.
    Czaja AJ
    Semin Liver Dis; 2002 Nov; 22(4):365-78. PubMed ID: 12447708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
    Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM
    Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.